Marimed (MRMD) Income towards Parent Company (2011 - 2026)

Marimed (MRMD) has 16 years of Income towards Parent Company data on file, last reported at -$3.8 million in Q1 2026.

• Income towards Parent Company for Q1 2026 came in at -$3.8 million, up 31.25% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.6 million (up 22.92% YoY), and the FY2025 annual result was -$14.5 million, down 16.3% from the prior year.
• Income towards Parent Company grew to -$3.8 million in Q1 2026 per MRMD's latest filing, from -$4.6 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $4.8 million in Q4 2022 and troughed at -$10.1 million in Q4 2023.
• A 5-year average of -$1.9 million and a median of -$1.3 million in 2024 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2022 and 2025: Income towards Parent Company soared 174.32% in 2022, then plunged 324.07% in 2025.
• A 5-year view of Income towards Parent Company shows it stood at $4.8 million in 2022, then sank by 313.23% to -$10.1 million in 2023, then grew by 18.49% to -$8.3 million in 2024, then soared by 43.84% to -$4.6 million in 2025, then advanced by 18.83% to -$3.8 million in 2026.
• Business Quant data shows MRMD's Income towards Parent Company at -$3.8 million in Q1 2026, -$4.6 million in Q4 2025, and -$2.9 million in Q3 2025.